LITEVAX
LiteVax is a biotechnology company that creates vaccines against infectious and non-infectious diseases.
LITEVAX
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Oss, Noord-Brabant, The Netherlands
Country:
The Netherlands
Website Url:
http://www.litevax.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Euro COVID-19 WP Rocket
Similar Organizations
Genoskin
Genoskin is a biotechnology company located in Toulouse.
Hera Biotech
Hera Biotech is a biotechnology company that is mainly developed for women's health and reproductive medicines.
Q-linea
Q-linea is a privately held company that develops and sells applications and systems for detecting, for example, biological warfare agents.
Synvia
Synvia is a holding company that focuses on innovation in drug studies, drug development and performing toxicological test services.
Vaiomer
Vaiomer is a biotech company and contract research organization expert in tissue and blood microbiota.
Official Site Inspections
http://www.litevax.com
- Host name: 203.157.214.35.bc.googleusercontent.com
- IP address: 35.214.157.203
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "LiteVax"
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine …
Sep 25, 2020 · LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy. New and more effective...See details»
LiteVax - Crunchbase Company Profile & Funding
LiteVax is a biotechnology company that creates vaccines against infectious and non-infectious diseases.See details»
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
Dec 14, 2020 · LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy.See details»
LiteVax - VentureRadar
LiteVax BV is a biopharmaceutical company focusing on the development and exploitation of novel adjuvant concepts. Our mission is to contribute to global health by delivering improved …See details»
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
Dec 14, 2020 · IPA and LiteVax selected the vaccine candidate following an assessment of the immunogenicity profiles of multiple SARS-CoV-2 vaccine candidates, each having an …See details»
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre
Sep 25, 2020 · -IMMUNOPRECISE ANTIBODIES LTD., a leader in full-service, therapeutic antibody discovery and development, and LiteVax BV, today announced that they have …See details»
Immunoprecise Says Collaborative Covid-19 Vaccine Project With …
June 22 (Reuters) - Immunoprecise Antibodies Ltd: * COLLABORATIVE COVID-19 VACCINE PROJECT BETWEEN IMMUNOPRECISE ANTIBODIES EUROPE AND LITEVAX BV, …See details»
ImmunoPrecise Antibodies (IPA) and LiteVax - genengnews.com
Candidate: Vaccine against SARS-CoV-2 Category: VAX Type: SARS-CoV-2 spike protein variant vaccine candidates from IPA, combined with LiteVax’s novel class of synthetic carbohydrate …See details»
Emerging Therapeutic Approaches to Combat COVID-19: Present …
Mar 8, 2021 · Coronavirus disease (COVID-19) has emerged as a fast-paced epidemic in late 2019 which is disrupting life-saving immunization services. SARS-CoV-2 is a highly …See details»
Retrospective analysis on the immunopotentiating mechanism of …
Jan 9, 2023 · We retrospectively analyzed the immunopotentiating mechanism of an oil-in-water (O/W) emulsion-based vaccine adjuvant LiteVaxâ„¢ Adjuvant (LVA) that contains CMS …See details»
Collaborative COVID-19 Vaccine Project Between ImmunoPrecise …
Jun 22, 2020 · LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy. New …See details»
Safety, tolerability, and immunogenicity of an inactivated SARS …
Jun 28, 2021 · Here we aimed to assess the safety, tolerability, and immunogenicity of a candidate COVID-19 vaccine, CoronaVac, containing inactivated SARS-CoV-2, in children and …See details»
A closer look at Canada's homegrown COVID-19 vaccine candidates
Oct 19, 2020 · The vaccine currently includes three spike protein fragments produced using genes inserted into mammalian cells. It also includes an adjuvant from Netherlands-based …See details»
Frontiers | Peer Reviewed Articles - Open Access Journals
We retrospectively analyzed the immunopotentiating mechanism of an oil-in-water (O/W) emulsion-based vaccine adjuvant LiteVaxâ„¢ Adjuvant (LVA) that contains CMS (Maltose 4’ …See details»
An adjuvanted SARS-CoV-2 RBD nanoparticle elicits ... - bioRxiv
Sep 9, 2021 · PPP and LHG are the founders and owners of LiteVax BV, the company that holds IP related to CMS. These commercial relationships are unrelated to the current study. FB, EN, …See details»
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre
Sep 25, 2020 · LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy. New …See details»
Vaccine adjuvants for infectious disease in the clinic
Mar 22, 2024 · LiteVax. LiteVax is a novel squalene emulsion formulation that maintains similarity to MF59 and AS03 with squalene being the main component at 80 mg/ml and the surfactant …See details»
Recent advances in vaccine and immunotherapy for COVID-19
Nov 6, 2020 · The virus entry. Coronaviruses enter into the host cells by using the viral S protein. 7 SARS-CoV-2 enters into the host cell by the interaction of its S protein with the host receptor …See details»
LiteVax BV - Company Profile - Tracxn
1 day ago · LiteVax BV is a Dutch biopharma developing vaccine adjuvants to improve efficacy of vaccines against infectious diseases. The company has developed and exploits two adjuvant …See details»
New patient animation sets out what to expect from a caesarean …
1 day ago · The RCOG has launched a new animation to support the informed consent process for pregnant women and birthing people planning a caesarean birth.See details»